The evolving immunotherapeutic landscape in advanced oesophagogastric cancer

Improvements in median overall survival in the advanced oesophagogastric (OG) setting have plateaued, underlining the need for improved therapeutic approaches in this patient population. Immunotherapeutics are inducing unexpected durable responses in an expanding list of advanced disease indications...

Descripción completa

Detalles Bibliográficos
Autores principales: Flynn, Michael, Young, Kate, Cunningham, David, Starling, Naureen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048671/
https://www.ncbi.nlm.nih.gov/pubmed/30034550
http://dx.doi.org/10.1177/1758835918786228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048671/
https://www.ncbi.nlm.nih.gov/pubmed/30034550
http://dx.doi.org/10.1177/1758835918786228

Ejemplares similares